Severe combined immunodeficiency with sensitivity to ionizing radiation
Severe combined immunodeficiency with sensitivity to ionizing radiation
Explore linked clinical trials. Standard reference: MESH:M05320501 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study of Transplantation of Autologous CD34+ Cells Transduced With the G2ARTE Lentiviral Vector Expressing the DCLRE1C cDNA in Artemis (DCLRE1C) Deficient Severe Combined Immunodeficiency Patients (ARTEGENE) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA repair disease, Infant, Newborn, Diseases, Nutritional and Metabolic Diseases, Primary Immunodeficiency Diseases, Severe combined immunodeficiency with sensitivity to ionizing radiation, hereditary disease, immune system disorder, inborn error of immunity, metabolic disease, severe combined immunodeficiency, xeroderma pigmentosum group F | Recruiting | Phase 1 / Phase 2 | 2026-03-27 | NCT05071222 |